2024 Q2 Form 10-K Financial Statement

#000190359624000245 Filed on April 16, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2023 Q4 2023
Revenue
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development $436.4K
YoY Change 285.36%
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $436.4K
YoY Change 285.36%
Operating Profit -$343.0K $1.454M
YoY Change 32.98% 159.39%
Interest Expense $14.16K $15.71K
YoY Change 444.69% 11.7%
% of Operating Profit 1.08%
Other Income/Expense, Net -$1.003M
YoY Change 147.79%
Pretax Income -$364.2K -$2.457M
YoY Change -37.58% 154.53%
Income Tax
% Of Pretax Income
Net Earnings -$364.2K -$2.457M
YoY Change -37.58% 154.53%
Net Earnings / Revenue
Basic Earnings Per Share $0.00
Diluted Earnings Per Share $0.00
COMMON SHARES
Basic Shares Outstanding 159.0M shares 154.4M shares
Diluted Shares Outstanding 159.0M shares

Balance Sheet

Concept 2024 Q2 2023 Q4 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $201.9K $108.3K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses $44.25K $4.133K
Receivables
Other Receivables
Total Short-Term Assets $246.2K $112.5K
YoY Change -78.21%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $246.2K $112.5K
Total Long-Term Assets $0.00 $0.00
Total Assets $246.2K $112.5K
YoY Change -78.21%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.258M $1.574M
YoY Change 17.26%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $2.258M $1.574M
Total Long-Term Liabilities
Total Liabilities $2.258M $1.574M
YoY Change 17.26%
SHAREHOLDERS EQUITY
Retained Earnings -$6.218M -$4.242M
YoY Change 137.55%
Common Stock $159.0K $155.5K
YoY Change -50.68%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$2.012M -$1.462M
YoY Change
Total Liabilities & Shareholders Equity $246.2K $112.5K
YoY Change -78.21%

Cashflow Statement

Concept 2024 Q2 2023 Q4 2023
OPERATING ACTIVITIES
Net Income -$364.2K -$2.457M
YoY Change -37.58% 154.53%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$647.9K
YoY Change 45.65%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $240.0K
YoY Change -71.29%
NET CHANGE
Cash From Operating Activities -$647.9K
Cash From Investing Activities
Cash From Financing Activities $240.0K
Net Change In Cash -$407.9K
YoY Change -204.26%
FREE CASH FLOW
Cash From Operating Activities -$647.9K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001960262
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
usd
CY2023 us-gaap Revenues
Revenues
usd
CY2022 us-gaap Revenues
Revenues
usd
CY2023 us-gaap Cost Of Revenue
CostOfRevenue
usd
CY2022 us-gaap Cost Of Revenue
CostOfRevenue
usd
CY2023 us-gaap Gross Profit
GrossProfit
usd
CY2022 us-gaap Gross Profit
GrossProfit
usd
CY2023 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
usd
CY2022 ludg Inducement Expense One
InducementExpenseOne
usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022 ludg Cancellation Of Common Stock
CancellationOfCommonStock
usd
CY2023 ludg Stock Issued For Services Related Party1
StockIssuedForServicesRelatedParty1
usd
CY2023 ludg Stock Issued For Option To Acquire Common Stock
StockIssuedForOptionToAcquireCommonStock
usd
CY2022 ludg Stock Issued For License Fee1
StockIssuedForLicenseFee1
usd
CY2023 ludg Stock Issued During Period Value Purchase Of Asset
StockIssuedDuringPeriodValuePurchaseOfAsset
usd
CY2022 ludg Inducement Expense
InducementExpense
usd
CY2023 us-gaap Extinguishment Of Debt Gain Loss Net Of Tax
ExtinguishmentOfDebtGainLossNetOfTax
usd
CY2022 us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
usd
CY2023 us-gaap Proceeds From Issuance Of Redeemable Preferred Stock
ProceedsFromIssuanceOfRedeemablePreferredStock
usd
CY2023 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
usd
CY2022 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
usd
CY2023 us-gaap Interest Paid
InterestPaid
usd
CY2022 us-gaap Interest Paid
InterestPaid
usd
CY2023 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2023 ludg Conversion Of Accrued Interest Into Convertible Notes Payable
ConversionOfAccruedInterestIntoConvertibleNotesPayable
usd
CY2022 ludg Conversion Of Notes Payable Into Common Stock
ConversionOfNotesPayableIntoCommonStock
usd
CY2023 ludg Debt Discount Beneficial Conversion Feature One
DebtDiscountBeneficialConversionFeatureOne
usd
CY2022 ludg Stock Repurchased And Returnable In Exchange For Note Payable Related Party
StockRepurchasedAndReturnableInExchangeForNotePayableRelatedParty
usd
CY2021Q4 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
usd
CY2023Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
usd
CY2023 us-gaap Income Tax Expense Benefit Continuing Operations Adjustment Of Deferred Tax Asset Liability
IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability
usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2023Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
usd
CY2022Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
usd
CY2023 dei Document Type
DocumentType
10-K
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-12-31
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Small Business
EntitySmallBusiness
true
CY2023 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2023 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023Q2 dei Entity Public Float
EntityPublicFloat
32575000 usd
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-12-31
CY2023 dei Auditor Firm
AuditorFirmId
5036
CY2023 dei Auditor Location
AuditorLocation
Margate, Florida
CY2023 dei Auditor Name
AuditorName
Assurance Dimensions
CY2022Q4 us-gaap Cash
Cash
516195 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
112468 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
516195 usd
CY2023Q4 us-gaap Assets
Assets
112468 usd
CY2022Q4 us-gaap Assets
Assets
516195 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
204024 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
6882 usd
CY2023Q4 us-gaap Notes Payable Current
NotesPayableCurrent
1270009 usd
CY2022Q4 us-gaap Notes Payable Current
NotesPayableCurrent
507136 usd
CY2023Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
100000 usd
CY2022Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
828344 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1574033 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1342362 usd
CY2023Q4 us-gaap Liabilities
Liabilities
1574033 usd
CY2022Q4 us-gaap Liabilities
Liabilities
1342362 usd
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
7000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
7000000 shares
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
7000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
7000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
7000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
7000000 shares
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
7000 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
7000 usd
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1250000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1250000000 shares
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
155464808 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
155464808 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
315188929 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
315188929 shares
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
155463 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2618454 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
637577 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-4242482 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1785932 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-1461565 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-826167 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
112468 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
516195 usd
CY2023 us-gaap Other General Expense
OtherGeneralExpense
1017470 usd
CY2022 us-gaap Other General Expense
OtherGeneralExpense
447260 usd
CY2023 ludg Research And Development In Expenses
ResearchAndDevelopmentInExpenses
436398 usd
CY2022 ludg Research And Development In Expenses
ResearchAndDevelopmentInExpenses
113245 usd
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
1453868 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
560505 usd
CY2023 us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
-1453868 usd
CY2022 us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
-560505 usd
CY2022 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
44475 usd
CY2023 ludg Inducement Expense One
InducementExpenseOne
-517454 usd
CY2022 us-gaap Interest Expense
InterestExpense
14068 usd
CY2023 ludg Amortization Of Debt Discount
AmortizationOfDebtDiscount
-469514 usd
CY2022 ludg Amortization Of Debt Discount
AmortizationOfDebtDiscount
-435052 usd
CY2023 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1002682 usd
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-404645 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2456550 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-965150 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-965150 usd
CY2023 ludg Basic And Diluted Loss Per Common Share
BasicAndDilutedLossPerCommonShare
-0.01
CY2022 ludg Basic And Diluted Loss Per Common Share
BasicAndDilutedLossPerCommonShare
-0.00
CY2023 ludg Weighted Average Number Of Common Shares Outstanding Basic And Diluted
WeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted
286563789 shares
CY2022 ludg Weighted Average Number Of Common Shares Outstanding Basic And Diluted
WeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted
313736463 shares
CY2022 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
6000 usd
CY2022 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
1000 usd
CY2022 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
91500 usd
CY2022 ludg Stock Issued For Services Related Party
StockIssuedForServicesRelatedParty
5200 usd
CY2022 ludg Stock Issued For Asset Purchase
StockIssuedForAssetPurchase
18000 usd
CY2022 ludg Debt Discount Beneficial Conversion Feature
DebtDiscountBeneficialConversionFeature
75000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-965150 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-826167 usd
CY2023 ludg Stock Issued For License Fee
StockIssuedForLicenseFee
370000 usd
CY2023 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
258713 usd
CY2023 ludg Stock Issued For Conversion Of Debt Including Inducement Expense
StockIssuedForConversionOfDebtIncludingInducementExpense
950152 usd
CY2023 ludg Stock Issued In Connection With Extension Of Notes And Convertible Notes Including Inducement Expense
StockIssuedInConnectionWithExtensionOfNotesAndConvertibleNotesIncludingInducementExpense
365160 usd
CY2023 ludg Stock Repurchased Exchange For Note Payable Related Party Net And Stock Cancelled
StockRepurchasedExchangeForNotePayableRelatedPartyNetAndStockCancelled
-122873 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-2456550 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-1461565 usd
CY2023 us-gaap Profit Loss
ProfitLoss
-2456550 usd
CY2022 us-gaap Profit Loss
ProfitLoss
-965150 usd
CY2023 ludg Stock Issued For Services
StockIssuedForServices
-258713 usd
CY2022 ludg Stock Issued For Services
StockIssuedForServices
-91500 usd
CY2022 ludg Stock Issued For Services Related Party1
StockIssuedForServicesRelatedParty1
5200 usd
CY2022 ludg Stock Issued For Option To Acquire Common Stock
StockIssuedForOptionToAcquireCommonStock
-1000 usd
CY2023 ludg Stock Issued For License Fee1
StockIssuedForLicenseFee1
370000 usd
CY2022 ludg Stock Issued During Period Value Purchase Of Asset
StockIssuedDuringPeriodValuePurchaseOfAsset
18000 usd
CY2023 ludg Amortization Of Debt Discount Premium One
AmortizationOfDebtDiscountPremiumOne
469514 usd
CY2022 ludg Amortization Of Debt Discount Premium One
AmortizationOfDebtDiscountPremiumOne
435052 usd
CY2023 ludg Inducement Expense
InducementExpense
517454 usd
CY2022 us-gaap Extinguishment Of Debt Gain Loss Net Of Tax
ExtinguishmentOfDebtGainLossNetOfTax
44475 usd
CY2023 us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
4133 usd
CY2023 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
197142 usd
CY2022 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
14068 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-647860 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-444805 usd
CY2022 us-gaap Proceeds From Issuance Of Redeemable Preferred Stock
ProceedsFromIssuanceOfRedeemablePreferredStock
6000 usd
CY2023 us-gaap Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
240000 usd
CY2022 us-gaap Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
830000 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
240000 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
836000 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-407860 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
391195 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
516195 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
125000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
108335 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
516195 usd
CY2023 ludg Cancellation Of Common Stock1
CancellationOfCommonStock1
171163 usd
CY2022 ludg Cancellation Of Common Stock1
CancellationOfCommonStock1
100 usd
CY2022 ludg Conversion Of Accrued Interest Into Convertible Notes Payable
ConversionOfAccruedInterestIntoConvertibleNotesPayable
9473 usd
CY2023 ludg Conversion Of Notes Payable Into Common Stock
ConversionOfNotesPayableIntoCommonStock
797858 usd
CY2023 ludg Original Issuance Debt Discount
OriginalIssuanceDebtDiscount
65000 usd
CY2022 ludg Original Issuance Debt Discount
OriginalIssuanceDebtDiscount
552857 usd
CY2022 ludg Debt Discount Beneficial Conversion Feature One
DebtDiscountBeneficialConversionFeatureOne
75000 usd
CY2023 ludg Reclassification From Convertible Notes To Notes Payable
ReclassificationFromConvertibleNotesToNotesPayable
640000 usd
CY2022 ludg Reclassification From Convertible Notes To Notes Payable
ReclassificationFromConvertibleNotesToNotesPayable
507136 usd
CY2023 ludg Stock Repurchased And Returnable In Exchange For Note Payable Related Party
StockRepurchasedAndReturnableInExchangeForNotePayableRelatedParty
122873 usd
CY2023 ludg Net Loss
NetLoss
2456550 usd
CY2023 ludg Net Cash Used In Operations
NetCashUsedInOperations
647860 usd
CY2023Q4 us-gaap Retained Earnings Appropriated
RetainedEarningsAppropriated
4242482 usd
CY2023Q4 ludg Working Capital Deficit
WorkingCapitalDeficit
1461565 usd
CY2023Q4 us-gaap Cash
Cash
108335 usd
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_843_eus-gaap--UseOfEstimates_z8kNdF11WsM9" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_86D_zxu7HXTxNL4">Use of Estimates</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Preparing financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and revenues and expenses during the reported period. Actual results could differ from those estimates, and those estimates may be material.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Changes in estimates are recorded in the period in which they become known. The Company bases its estimates on historical experience and other assumptions, which include both quantitative and qualitative assessments that it believes to be reasonable under the circumstances.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Significant estimates during the years ended December 31, 2023 and 2022 include valuation of stock-based compensation, uncertain tax positions, and the valuation allowance on deferred tax assets.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
CY2023Q4 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
0 usd
CY2022Q4 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
256583 usd
CY2023 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
436398 usd
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
113245 usd
CY2023 us-gaap Advertising Expense
AdvertisingExpense
135576 usd
CY2022 us-gaap Advertising Expense
AdvertisingExpense
79931 usd
CY2023 us-gaap Payments For Repurchase Of Convertible Preferred Stock
PaymentsForRepurchaseOfConvertiblePreferredStock
700000000 usd
CY2022 us-gaap Payments For Repurchase Of Convertible Preferred Stock
PaymentsForRepurchaseOfConvertiblePreferredStock
700000000 usd
CY2023 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p id="xdx_840_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_z4fTxIEtPQad" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_866_z3bYObiHDoM7">New Accounting Standard Adopted</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In August 2020, FASB issued ASU 2020-06, Accounting for Convertible Instruments and Contracts in an Entity; Own Equity (“ASU 2020-06”), as part of its overall simplification initiative to reduce costs and complexity of applying accounting standards while maintaining or improving the usefulness of the information provided to users of financial statements. Among other changes, the new guidance removes from GAAP separation models for convertible debt that require the convertible debt to be separated into a debt and equity component, unless the conversion feature is required to be bifurcated and accounted for as a derivative or the debt is issued at a substantial premium. As a result, after adopting the guidance,</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">entities will no longer separately present such embedded conversion features in equity and will instead account for the convertible debt wholly as debt. The new guidance also requires use of the “if-converted” method when calculating the dilutive impact of convertible debt on earnings per share, which is consistent with the Company’s current accounting treatment under the current guidance. The guidance is effective for financial statements issued for fiscal years beginning after December 15, 2023, and interim periods within those fiscal years, with early adoption permitted, but only at the beginning of the fiscal year.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">This guidance will be adopted on January 1, 2024. The Company is evaluating the impact that the adoption of ASU 2020-06 might have on the Company’s consolidated financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In March 2022, the Financial Accounting Standards Board (the “FASB”) issued ASU 2022-02, Financial Instruments – Credit Losses (Topic 326): Troubled Debt Restructurings and Vintage Disclosures (“ASU 2022-02”), which eliminates the accounting guidance on troubled debt restructurings (“TDRs”) for creditors in ASC 310, Receivables (Topic 310), and requires entities to provide disclosures about current period gross write-offs by year of origination. Also, ASU 2022-02 updates the requirements related to accounting for credit losses under ASC 326, Financial Instruments – Credit Losses (Topic 326), and adds enhanced disclosures for creditors with respect to loan refinancings and restructurings for borrowers experiencing financial difficulty. ASU 2022-02 was effective for the Company January 1, 2023. The adoption of ASU 2022-02 did not have a material impact on the Company’s consolidated financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">This guidance was adopted on January 1, 2023. The adoption of ASU 2022-02 did not have a material impact on the Company’s consolidated financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
CY2021Q4 us-gaap Notes Payable
NotesPayable
135955 usd
CY2022 us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
150000 usd
CY2022 ludg Original Issue Debt Discount
OriginalIssueDebtDiscount
-75000 usd
CY2022 ludg Amortization Of Debt Discount Premium1
AmortizationOfDebtDiscountPremium1
296181 usd
CY2022Q4 us-gaap Notes Payable
NotesPayable
507136 usd
CY2023 us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
122873 usd
CY2022 ludg Reclassifications Amount Net
ReclassificationsAmountNet
640000 usd
CY2023Q4 us-gaap Notes Payable
NotesPayable
1270009 usd
CY2023Q4 us-gaap Other Notes Payable Current
OtherNotesPayableCurrent
1270009 usd
CY2022Q4 us-gaap Other Notes Payable Current
OtherNotesPayableCurrent
507136 usd
CY2022 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
1307857 usd
CY2022 ludg Original Issue Debt Discount Convertible Notes Payable
OriginalIssueDebtDiscountConvertibleNotesPayable
-552857 usd
CY2022 ludg Debt Discount Beneficial Conversion Feature Note1
DebtDiscountBeneficialConversionFeatureNote1
-75000 usd
CY2022 ludg Convertible Notes Payable Note Discount
ConvertibleNotesPayableNoteDiscount
138871 usd
CY2022 ludg Conversion Of Accrued Interest Into Convertible Notes Payable One
ConversionOfAccruedInterestIntoConvertibleNotesPayableOne
9473 usd
CY2022Q4 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
828344 usd
CY2023 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
305000 usd
CY2023 ludg Debt Discount Beneficial Conversion Feature Note
DebtDiscountBeneficialConversionFeatureNote
-640000 usd
CY2023 ludg Convertible Notes Payable Note Discount
ConvertibleNotesPayableNoteDiscount
-65000 usd
CY2023 ludg Amortization Of Debt Discount1
AmortizationOfDebtDiscount1
469514 usd
CY2023 ludg Conversion Of Debt Into Common Stock One
ConversionOfDebtIntoCommonStockOne
-797858 usd
CY2023Q4 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
100000 usd
CY2023Q4 us-gaap Long Term Debt
LongTermDebt
100000 usd
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
1232857 usd
CY2022Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
404513 usd
CY2023Q4 ludg Convertible Notes Payable Net
ConvertibleNotesPayableNet
100000 usd
CY2022Q4 ludg Convertible Notes Payable Net
ConvertibleNotesPayableNet
828344 usd
CY2023Q4 ludg Fair Value Of Common Stock On Conversion Date
FairValueOfCommonStockOnConversionDate
445714 usd
CY2023Q4 ludg Fair Value Of Debt Subject To Inducement
FairValueOfDebtSubjectToInducement
342857 usd
CY2023Q4 ludg Inducement Debt Expense
InducementDebtExpense
102857 usd
CY2023 ludg Debtprior To Modification
DebtpriorToModification
151611 usd
CY2023 ludg Debtafter Modification
DebtafterModification
107136 usd
CY2023 ludg Gain On Debt Extinguishment
GainOnDebtExtinguishment
44475 usd
CY2023 ludg Monthly Payment
MonthlyPayment
3750 usd
CY2023 ludg Accrued Monthly
AccruedMonthly
5000 usd
CY2023 ludg Monthly Payment Second
MonthlyPaymentSecond
5000 usd
CY2023 ludg Second Accrued Monthly
SecondAccruedMonthly
3750 usd
CY2023 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-177000 usd
CY2022 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-194000 usd
CY2023 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-37000 usd
CY2022 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-43000 usd
CY2022 us-gaap Income Tax Expense Benefit Continuing Operations Adjustment Of Deferred Tax Asset Liability
IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability
-11000 usd
CY2023 us-gaap Other Tax Expense Benefit
OtherTaxExpenseBenefit
-214000 usd
CY2022 us-gaap Other Tax Expense Benefit
OtherTaxExpenseBenefit
-248000 usd
CY2023 ludg Change In Valuation Allowance
ChangeInValuationAllowance
214000 usd
CY2022 ludg Change In Valuation Allowance
ChangeInValuationAllowance
248000 usd
CY2023Q4 ludg Debt Instrument Unamortized Discount1
DebtInstrumentUnamortizedDiscount1
119000 usd
CY2022Q4 ludg Debt Instrument Unamortized Discount1
DebtInstrumentUnamortizedDiscount1
87000 usd
CY2023Q4 ludg Share Based Payments
ShareBasedPayments
-290000 usd
CY2022Q4 ludg Share Based Payments
ShareBasedPayments
-28000 usd
CY2023Q4 us-gaap Deferred Tax Asset Interest Carryforward
DeferredTaxAssetInterestCarryforward
366000 usd
CY2022Q4 us-gaap Deferred Tax Asset Interest Carryforward
DeferredTaxAssetInterestCarryforward
294000 usd
CY2023Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
775000 usd
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
409000 usd
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
775000 usd
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
409000 usd

Files In Submission

Name View Source Status
0001903596-24-000245-index-headers.html Edgar Link pending
0001903596-24-000245-index.html Edgar Link pending
0001903596-24-000245.txt Edgar Link pending
0001903596-24-000245-xbrl.zip Edgar Link pending
ex21_1.htm Edgar Link pending
ex31_1.htm Edgar Link pending
ex31_2.htm Edgar Link pending
ex32_1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
image_002.jpg Edgar Link pending
ludg-20231231.xsd Edgar Link pending
ludg_1.jpg Edgar Link pending
ludg_10k.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
ludg-20231231_def.xml Edgar Link unprocessable
ludg-20231231_pre.xml Edgar Link unprocessable
ludg-20231231_lab.xml Edgar Link unprocessable
ludg_10k_htm.xml Edgar Link completed
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
ludg-20231231_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable